Related references
Note: Only part of the references are listed.Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems
Krisztina Kiss et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
Ivan Randelovic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin-GnRH-III conjugates developed for targeted drug delivery
Sabine Schuster et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2018)
Development of novel cyclic NGR peptide-daunomycin conjugates with dual targeting property
Andrea Angelo Pierluigi Tripodi et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2018)
NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
Khaled Seidi et al.
ONCOGENE (2018)
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
Sabine Schuster et al.
PHARMACEUTICS (2018)
Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain
Ryota Kirikoshi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
NGR-peptide-drug conjugates with dual targeting properties
Kata Nora Enyedi et al.
PLOS ONE (2017)
Intracaecal Orthotopic Colorectal Cancer Xenograft Mouse Model
Hsin-Wei Liao et al.
BIO-PROTOCOL (2017)
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice
Bence Kapuvari et al.
INVESTIGATIONAL NEW DRUGS (2016)
Development of Cyclic NGR Peptides with Thioether Linkage: Structure and Dynamics Determining Deamidation and Bioactivity
Kata Nora Enyedi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Animal models of human colorectal cancer: Current status, uses and limitations
Vijay K. Mittal et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming
Leila Cancian et al.
TRENDS IN CELL BIOLOGY (2013)
Targeted Drug Delivery and Penetration Into Solid Tumors
Angelo Corti et al.
MEDICINAL RESEARCH REVIEWS (2012)
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
Simon L. Goodman et al.
BIOLOGY OPEN (2012)
In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites
Erika Orban et al.
AMINO ACIDS (2011)
Use of Metadynamics in the Design of isoDGR-Based alpha nu beta 3 Antagonists To Fine-Tune the Conformational Ensemble
Andrea Spitaleri et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Angelo Corti et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Conformational Control of Integrin-Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch
Andreas O. Frank et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching
Flavio Curnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome
Ayele H. Negussie et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells
Bala Chandran
JOURNAL OF VIROLOGY (2010)
Peptide Targeting of Platinum Anti-Cancer Drugs
Margaret W. Ndinguri et al.
BIOCONJUGATE CHEMISTRY (2009)
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience
Ralf Bieker et al.
BLOOD (2009)
Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature
Sumitra Mukhopadhyay et al.
BIOCONJUGATE CHEMISTRY (2008)
The neovasculature homing motif NGR: more than meets the eye
Angelo Corti et al.
BLOOD (2008)
Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots
Marlies Ostendorp et al.
CANCER RESEARCH (2008)
Structural basis for the interaction of isoDGR with the RGD-binding site of αvβ3 integrin
Andrea Spitaleri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
In vivo optical imaging of CD13/APN-expression in tumor xenografts
Angelika von Wallbrunn et al.
JOURNAL OF BIOMEDICAL OPTICS (2008)
Monoclonal antibody 14C5 targets integrin αvβ3
Ingrid Burvenich et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The moonlighting enzyme CD13: old and new functions to target
Paola Mina-Osorio
TRENDS IN MOLECULAR MEDICINE (2008)
Integrin αVβ3 binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptor
H. Jacques Garrigues et al.
JOURNAL OF VIROLOGY (2008)
Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting
Xiao-Qing Qiu et al.
NATURE BIOTECHNOLOGY (2007)
Impaired angiogenesis in aminopeptidase N-null mice
Roberto Rangel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The structure and main functions of aminopeptidase N
Yepeng Luan et al.
CURRENT MEDICINAL CHEMISTRY (2007)
cNGR: A novel homing sequence for CD13/APN targeted molecular imaging of murine cardiac angiogenesis in vivo
Alexandra Buehler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis
Kazuteru Fukasawa et al.
CANCER LETTERS (2006)
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy
Fabio Pastorino et al.
CANCER RESEARCH (2006)
Natural killer cells in breast cancer cell growth and metastasis in SCID mice
MZ Dewan et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth
Y Yokoyama et al.
CANCER (2005)
Synthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil
Z Zhang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2005)
Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor α coupled to NGR and RGD tumor-homing peptides
N Zarovni et al.
HUMAN GENE THERAPY (2004)
Clinical translation of angiogenesis inhibitors
R Kerbel et al.
NATURE REVIEWS CANCER (2002)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
Protein deamidation
NE Robinson
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Aminopeptidase N is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer
H Hashida et al.
GASTROENTEROLOGY (2002)
CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
SV Bhagwat et al.
BLOOD (2001)
Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
F Curnis et al.
NATURE BIOTECHNOLOGY (2000)
Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature
T Simonart et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
